FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Boothwyn Pharmacy Fluorescein 2% Ophth Recall

Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496

Boothwyn Pharmacy LLC · Kennett Square, PA

Risk level
Class III
Reported by FDA
Sep 10, 2025
Recall ID
D-0607-2025
Check your lot numberHow we source this data

Summary

Boothwyn Pharmacy recalled Fluorescein 2% Ophth starting Jul 9, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0607-2025 on Sep 10, 2025. Reason: Subpotent Drug. Status: Ongoing.

Why it was recalled

Subpotent Drug

Product description

Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496

Lot numbers, UPCs & expiration codes

06092025@23 BUD 09/09/2025

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0607-2025
Classification
Class III
Status
Ongoing
Recall initiated
Jul 9, 2025
FDA report date
Sep 10, 2025
Quantity
8 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Boothwyn Pharmacy LLC

Original FDA data

Every field from FDA enforcement report D-0607-2025, exactly as published.

Show all FDA fields
City
Kennett Square
State
PA
Status
Ongoing
Country
United States
Event ID
97202
Address
221 Gale Ln
Code information
06092025@23 BUD 09/09/2025
Postal code
19348
Report date
Sep 10, 2025
Product type
Drugs
Recall number
D-0607-2025
Classification
Class III
Recalling firm
Boothwyn Pharmacy LLC
Product quantity
8 vials
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496
Distribution pattern
U.S. Nationwide
Recall initiation date
Jul 9, 2025
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Aug 29, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0607-2025, published Sep 10, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls